IGHE and asthma: Avoiding supplementation with CMF effectively reduced the risk of asthma or recurrent wheeze only in the subgroup of infants with the highest quartile levels of total IgE (ie, ≥50 IU/mL) at age 24 months and in the subgroups of those with positive mite-, milk-, and wheat-specific IgE.